title: Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer.
abstract: High-risk susceptibility genes explain <40% of the excess risk of familial ovarian cancer. Therefore, other ovarian cancer susceptibility genes are likely to exist. We have used a single nucleotide polymorphism (SNP)-tagging approach to evaluate common variants in 13 genes involved in cell cycle control-CCND1, CCND2, CCND3, CCNE1, CDK2, CDK4, CDK6, CDKN1A, CDKN1B, CDKN2A, CDKN2B, CDKN2C, and CDKN2D-and risk of invasive epithelial ovarian cancer. We used a two-stage, multicenter, case-control study. In stage 1, 88 SNPs that tag common variation in these genes were genotyped in three studies from the United Kingdom, United States, and Denmark ( approximately 1,500 cases and 2,500 controls). Genotype frequencies in cases and controls were compared using logistic regression. In stage 2, eight other studies from Australia, Poland, and the United States ( approximately 2,000 cases and approximately 3,200 controls) were genotyped for the five most significant SNPs from stage 1. No SNP was significant in the stage 2 data alone. Using the combined stages 1 and 2 data set, CDKN2A rs3731257 and CDKN1B rs2066827 were associated with disease risk (unadjusted P trend = 0.008 and 0.036, respectively), but these were not significant after adjusting for multiple testing. Carrying the minor allele of these SNPs was found to be associated with reduced risk [OR, 0.91 (0.85-0.98) for rs3731257; and OR, 0.93 (0.87-0.995) for rs2066827]. In conclusion, we have found evidence that a single tagged SNP in both the CDKN2A and CDKN1B genes may be associated with reduced ovarian cancer risk. This study highlights the need for multicenter collaborations for genetic association studies.
authors.affiliation: Translational Research Laboratories, University College London, London, United Kingdom. s.gayther@ucl.ac.uk
authors.forename: Simon A
authors.initials: SA
authors.lastname: Gayther
authors.forename: Honglin
authors.initials: H
authors.lastname: Song
authors.forename: Susan J
authors.initials: SJ
authors.lastname: Ramus
authors.forename: Susan Krüger
authors.initials: SK
authors.lastname: Kjaer
authors.forename: Alice S
authors.initials: AS
authors.lastname: Whittemore
authors.forename: Lydia
authors.initials: L
authors.lastname: Quaye
authors.forename: Jonathan
authors.initials: J
authors.lastname: Tyrer
authors.forename: Danielle
authors.initials: D
authors.lastname: Shadforth
authors.forename: Estrid
authors.initials: E
authors.lastname: Hogdall
authors.forename: Claus
authors.initials: C
authors.lastname: Hogdall
authors.forename: Jan
authors.initials: J
authors.lastname: Blaeker
authors.forename: Richard
authors.initials: R
authors.lastname: DiCioccio
authors.forename: Valerie
authors.initials: V
authors.lastname: McGuire
authors.forename: Penelope M
authors.initials: PM
authors.lastname: Webb
authors.forename: Jonathan
authors.initials: J
authors.lastname: Beesley
authors.forename: Adele C
authors.initials: AC
authors.lastname: Green
authors.forename: David C
authors.initials: DC
authors.lastname: Whiteman
authors.forename: Marc T
authors.initials: MT
authors.lastname: Goodman
authors.forename: Galina
authors.initials: G
authors.lastname: Lurie
authors.forename: Michael E
authors.initials: ME
authors.lastname: Carney
authors.forename: Francesmary
authors.initials: F
authors.lastname: Modugno
authors.forename: Roberta B
authors.initials: RB
authors.lastname: Ness
authors.forename: Robert P
authors.initials: RP
authors.lastname: Edwards
authors.forename: Kirsten B
authors.initials: KB
authors.lastname: Moysich
authors.forename: Ellen L
authors.initials: EL
authors.lastname: Goode
authors.forename: Fergus J
authors.initials: FJ
authors.lastname: Couch
authors.forename: Julie M
authors.initials: JM
authors.lastname: Cunningham
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Sellers
authors.forename: Anna H
authors.initials: AH
authors.lastname: Wu
authors.forename: Malcolm C
authors.initials: MC
authors.lastname: Pike
authors.forename: Edwin S
authors.initials: ES
authors.lastname: Iversen
authors.forename: Jeffrey R
authors.initials: JR
authors.lastname: Marks
authors.forename: Montserrat
authors.initials: M
authors.lastname: Garcia-Closas
authors.forename: Louise
authors.initials: L
authors.lastname: Brinton
authors.forename: Jolanta
authors.initials: J
authors.lastname: Lissowska
authors.forename: Beata
authors.initials: B
authors.lastname: Peplonska
authors.forename: Douglas F
authors.initials: DF
authors.lastname: Easton
authors.forename: Ian
authors.initials: I
authors.lastname: Jacobs
authors.forename: Bruce A J
authors.initials: BA
authors.lastname: Ponder
authors.forename: Joellen
authors.initials: J
authors.lastname: Schildkraut
authors.forename: C Leigh
authors.initials: CL
authors.lastname: Pearce
authors.forename: Georgia
authors.initials: G
authors.lastname: Chenevix-Trench
authors.forename: Andrew
authors.initials: A
authors.lastname: Berchuck
authors.forename: Paul D P
authors.initials: PD
authors.lastname: Pharoah
mesh_terms: D016022:Case-Control Studies; D002453:Cell Cycle / Q000235:genetics; D018797:Cell Cycle Proteins / Q000235:genetics; D018844:Cyclin-Dependent Kinases / Q000235:genetics; D016213:Cyclins / Q000235:genetics; D005260:Female; D018816:Genes, cdc; D020022:Genetic Predisposition to Disease; D006801:Humans; D010051:Ovarian Neoplasms / Q000235:genetics* / Q000473:pathology; D020641:Polymorphism, Single Nucleotide
chemical_list: D018797:Cell Cycle Proteins; D016213:Cyclins; D018844:Cyclin-Dependent Kinases